MEDICENNA BY THE NUMBERS

1

Focused on ONE Target: the IL4R

20

Number of Caners Known to Over-Express the IL4R

1 Million

Annual Incidence of IL4R Positive Cancers

30+ Million

Non-Dilutive Grant and Equity (Funding in Cdn$)

40

Number of Patents Filed or Issued

250,000

Annual Incidence of Glioblastoma and Metastatic Brain Cancer

10,000

Brain Tumor Patients that can be treated with 2 Grams of MDNA55

2 Billion

Potential Market of MDNA55 Market for Brain Cancer ($US)

HOPE

Top